Literature DB >> 21315781

Physical and chemical stability of drug nanoparticles.

Libo Wu1, Jian Zhang, Wiwik Watanabe.   

Abstract

As nano-sizing is becoming a more common approach for pharmaceutical product development, researchers are taking advantage of the unique inherent properties of nanoparticles for a wide variety of applications. This article reviews the physical and chemical stability of drug nanoparticles, including their mechanisms and corresponding characterization techniques. A few common strategies to overcome stability issues are also discussed. Published by Elsevier B.V.

Mesh:

Substances:

Year:  2011        PMID: 21315781     DOI: 10.1016/j.addr.2011.02.001

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  109 in total

1.  Development and characterisation of ursolic acid nanocrystals without stabiliser having improved dissolution rate and in vitro anticancer activity.

Authors:  Ju Song; Yancai Wang; Yuelin Song; Hokman Chan; Chao Bi; Xiao Yang; Ru Yan; Yitao Wang; Ying Zheng
Journal:  AAPS PharmSciTech       Date:  2014-02       Impact factor: 3.246

Review 2.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

3.  A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances.

Authors:  Peng Liu; Yanbin Zhou; Xinyi Shi; Yu Yuan; Ying Peng; Surong Hua; Qiange Luo; Jinsong Ding; Yong Li; Wenhu Zhou
Journal:  J Nanobiotechnology       Date:  2021-05-21       Impact factor: 10.435

Review 4.  The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions?

Authors:  Alice Panariti; Giuseppe Miserocchi; Ilaria Rivolta
Journal:  Nanotechnol Sci Appl       Date:  2012-09-07

5.  Classification of the crystallization tendency of active pharmaceutical ingredients (APIs) and nutraceuticals based on their nucleation and crystal growth behaviour in solution state.

Authors:  Sneha Rathi; Rahul B Chavan; Nalini R Shastri
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

6.  Design and synthesis of theranostic antibiotic nanodrugs that display enhanced antibacterial activity and luminescence.

Authors:  Sheng Xie; Sesha Manuguri; Giampiero Proietti; Joakim Romson; Ying Fu; A Ken Inge; Bin Wu; Yang Zhang; Daniel Häll; Olof Ramström; Mingdi Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-25       Impact factor: 11.205

Review 7.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

8.  Particle Surface Roughness Improves Colloidal Stability of Pressurized Pharmaceutical Suspensions.

Authors:  Hui Wang; David S Nobes; Reinhard Vehring
Journal:  Pharm Res       Date:  2019-01-30       Impact factor: 4.200

9.  Ion-ion correlation, solvent excluded volume and pH effects on physicochemical properties of spherical oxide nanoparticles.

Authors:  Zaven Ovanesyan; Amal Aljzmi; Manal Almusaynid; Asrar Khan; Esteban Valderrama; Kelly L Nash; Marcelo Marucho
Journal:  J Colloid Interface Sci       Date:  2015-10-08       Impact factor: 8.128

Review 10.  Advances and limitations of drug delivery systems formulated as eye drops.

Authors:  Clotilde Jumelle; Shima Gholizadeh; Nasim Annabi; Reza Dana
Journal:  J Control Release       Date:  2020-02-03       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.